Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

KZIA

Kazia Therapeuti

NASDAQ

0.4026

-0.0141

-3.38%

After Hours: 0.4026 0 0.00% 16:08 07/26 EDT

OPEN

0.4178

PREV CLOSE

0.4167

HIGH

0.4300

LOW

0.3901

VOLUME

1.19M

TURNOVER

52 WEEK HIGH

1.580

52 WEEK LOW

0.1866

MARKET CAP

11.99M

P/E (TTM)

-0.5438

Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics

Kazia Therapeutics (NASDAQ:KZIA) is an Australian biotechnology company that develops cancer drugs. The company recently completed a positive clinical-trial results for its primary drug. KaziaTherapeutics stock skyrocketed to a 52-week high of $1.58 before falling to 53 cents.

Investorplace · 1d ago

Weekly Report: what happened at KZIA last week (0715-0719)?

Weekly Report · 4d ago

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

SolarEdge Technologies, Inc. Shares dipped 12.2% to $27.77 on Monday after the company announced a workforce reduction. Trump Media & Technology Group Corp. Shares rose 32.8% following the attempted assassination of Donald Trump. Shares of prison and firearm stocks traded higher following the attack.

Benzinga · 07/15 17:23

Weekly Report: what happened at KZIA last week (0708-0712)?

Weekly Report · 07/15 10:22

S&P 500 Rises Over 1%; Citigroup Reports Upbeat Q2 Results

The Dow Jones index surged past the 40,000 mark on Friday. The Dow traded up 1.09% to 40,187.34 while the NASDAQ rose 1.30%. Citigroup reported better-than-expected results for its second quarter. Information technology shares jumped by 1.5% on Friday; communication services shares fell 0.2%. Euro zone European shares closed higher today. Asian markets closed mixed in Asia Pacific markets.

Benzinga · 07/12 18:31

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

ASP Isotopes Inc. Shares fell 9.2% to $3.2308 on Friday. The company announced pricing of a $30 million public offering of 12 million shares at $2.50 per share. Vicinity Motor Corp. Shares jumped 133.2%. Other stocks moving in today's mid-day session.

Benzinga · 07/12 17:15

Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings

U.S. Stocks traded higher midway through trading on Friday. The Dow traded up 0.85% while the Nasdaq Composite gained around 1%. JPMorgan Chase & Co. Reported better-than-expected second-quarter FY24 results. Information technology shares jumped by 1.5% on Friday; communication services shares fell by 0.2%. Asian markets closed mixed on Friday with Japan's Nikkei falling 2.45%.

Benzinga · 07/12 16:00

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that warrant attention. The Benzinga stock whisper index for the week of July 12 includes five stocks with strong interest from readers. Kazia Therapeutics is the smallest stock on this week's index and is up 500% in the last week.

Benzinga · 07/12 15:36

About KZIA

Kazia Therapeutics Limited is an oncology focused drug development company. The Company is engaged in the pharmaceutical research and development. Its lead program includes Paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3), which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. EVT801 is an inhibitor of VEGFR3, a cellular receptor for VEGF. The Company’s drug candidates are designed to treat disease, such as brain cancer, renal cancer, and liver cancer.

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.